Literature DB >> 4451601

Aetiology of prolonged apnoea after suxamethonium.

H W Bauld, P F Gibson, P J Jebson, S S Brown.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4451601     DOI: 10.1093/bja/46.4.273

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  7 in total

1.  Rapid degradation of oseltamivir phosphate in clinical samples by plasma esterases.

Authors:  Niklas Lindegardh; Geraint R Davies; Tinh Hien Tran; Jeremy Farrar; Pratap Singhasivanon; Nicholas P J Day; Nicholas J White
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Hospital anaesthesia and general practice.

Authors:  I H Shaw; J M Evans
Journal:  BMJ       Date:  1988-12-03

3.  Genetic Testing for BCHE Variants Identifies Patients at Risk of Prolonged Neuromuscular Blockade in Response to Succinylcholine.

Authors:  Guang-Dan Zhu; Eric Dawson; Angela Huskey; Ronald J Gordon; Andria L Del Tredici
Journal:  Pharmgenomics Pers Med       Date:  2020-09-30

4.  Cholinesterase Newfoundland: a new succinylcholine-sensitive variant of cholinesterase at locus 1.

Authors:  N E Simpson; C R Elliott
Journal:  Am J Hum Genet       Date:  1981-05       Impact factor: 11.025

5.  Supramolecular therapeutics to treat the side effects induced by a depolarizing neuromuscular blocking agent.

Authors:  Xiangjun Zhang; Qian Cheng; Lanlan Li; Liqing Shangguan; Chenwen Li; Shengke Li; Feihe Huang; Jianxiang Zhang; Ruibing Wang
Journal:  Theranostics       Date:  2019-05-18       Impact factor: 11.556

6.  Butyryl-cholinesterase deficiency: A case report of delayed recovery after general anaesthesia.

Authors:  Ahmed Al-Emam
Journal:  Toxicol Rep       Date:  2021-06-17

7.  Reversal of succinylcholine induced apnea with an organophosphate scavenging recombinant butyrylcholinesterase.

Authors:  Brian C Geyer; Katherine E Larrimore; Jacquelyn Kilbourne; Latha Kannan; Tsafrir S Mor
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.